Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study
Conclusions: Since a similar trend was seen in both groups, our study concluded no additional role of remdesivir in combating COVID-19.
Source: The Journal of Infection in Developing Countries - Category: Infectious Diseases Authors: Nithish Sattoju, Santosh Gattu, Sai Sashank Merugu, Vydhika Anneboina, Sai Ram Ganapaka Source Type: research
More News: Coronavirus | Cough | COVID-19 | Dexamethasone | Infectious Diseases | International Medicine & Public Health | Study | WHO